USMGC Set to Acquire Polyisoprene Chemical FacilityUSMGC Set to Acquire Polyisoprene Chemical Facility

The company also launched an independent division to oversee the production of raw nitrile and polyisoprene.

Omar Ford

August 6, 2024

1 Min Read
Image Credit: Hans Neleman via Getty Images

U.S. Medical Glove Company (USMGC) said it has acquired a polyisoprene chemical facility. The Harvard, IL-based company said the acquisition make it the only end-to-end Made-in-America manufacturer of both nitrile and polyisoprene gloves.

USMGC did not reveal additional details about the deal.

Alongside the acquisition, USMGC launched an independent division to oversee the production of raw nitrile and polyisoprene, crucial ingredients in both surgical and medical exam gloves.

The new division is U.S. Medical Chemical Company (USMCC), which will exclusively supply USMGC with the raw materials required to manufacture a suite of personal protective equipment (PPE) to fulfill contracts across the U.S. government, including agencies such as the U.S. Army, FEMA, U.S. Customs and Border Protection, and USPS.

"The PPE shortages prevalent through the pandemic proved how critical American control of the supply chain was in safeguarding American health and security," Alex Todoroki of USMGC said in a release. "By adding this facility to our portfolio, USMGC has now secured the raw supplies, advanced machinery, and 30+ production lines to manufacture 2.5 billion nitrile and polyisoprene surgical gloves by the end of 2024. We are incredibly proud that our entire supply chain is 100% made in America."

About the Author

Omar Ford

Omar Ford is a veteran reporter in the field of medical technology and healthcare journalism. As Editor-in-Chief of MD+DI (Medical Device and Diagnostics Industry), a leading publication in the industry, Ford has established himself as an authoritative voice and a trusted source of information.

Ford, who has a bachelor's degree in print journalism from the University of South Carolina, has dedicated his career to reporting on the latest advancements and trends in the medical device and diagnostic sector.

During his tenure at MD+DI, Ford has covered a wide range of topics, including emerging medical technologies, regulatory developments, market trends, and the rise of artificial intelligence. He has interviewed influential leaders and key opinion leaders in the field, providing readers with valuable perspectives and expert analysis.

 

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like